search
Insilico Medicine
Trends
- 1Insilico Medicine signs multimillion AI drug discovery deal▼Insilico Medicine strikes tens-of-millions AI co-development deal with unnamed foundation-model lab
Insilico Medicine has signed a co-development deal worth tens of millions of dollars with an unnamed foundation-model laboratory, joining forces to apply large AI models to drug discovery. The Hong Kong-based biotech, known for using generative AI to design drug candidates, has not disclosed its partner or the exact terms, leaving observers speculating about which AI lab is behind the agreement.